img

Global Metastatic Prostate Cancer Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Metastatic Prostate Cancer Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.
Metastatic Prostate Cancer Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Metastatic Prostate Cancer Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Metastatic Prostate Cancer Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Metastatic Prostate Cancer Treatment key companies include AB Science, BeiGene, eFFECTOR Therapeutics, Immunomedics(Gilead Sciences, Inc.), Myovant Biosciences, SeleXel, Zenith Epigenetics Ltd., VasGene Therapeutics, Inc. and Telix Pharmaceuticals, etc. AB Science, BeiGene, eFFECTOR Therapeutics are top 3 players and held % share in total in 2022.
Metastatic Prostate Cancer Treatment can be divided into Mono, Combination and Mono/Combination,, etc. Mono is the mainstream product in the market, accounting for % share globally in 2022.
Metastatic Prostate Cancer Treatment is widely used in various fields, such as Hospital, Drug Store and Online Pharmacy,, etc. Hospital provides greatest supports to the Metastatic Prostate Cancer Treatment industry development. In 2022, global % share of Metastatic Prostate Cancer Treatment went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Metastatic Prostate Cancer Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech
Segment by Type
Mono
Combination
Mono/Combination

Segment by Application


Hospital
Drug Store
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Metastatic Prostate Cancer Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Metastatic Prostate Cancer Treatment introduction, etc. Metastatic Prostate Cancer Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Metastatic Prostate Cancer Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Metastatic Prostate Cancer Treatment
1.1 Metastatic Prostate Cancer Treatment Market Overview
1.1.1 Metastatic Prostate Cancer Treatment Product Scope
1.1.2 Metastatic Prostate Cancer Treatment Market Status and Outlook
1.2 Global Metastatic Prostate Cancer Treatment Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Metastatic Prostate Cancer Treatment Market Size by Region (2018-2034)
1.4 Global Metastatic Prostate Cancer Treatment Historic Market Size by Region (2018-2024)
1.5 Global Metastatic Prostate Cancer Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Metastatic Prostate Cancer Treatment Market Size (2018-2034)
1.6.1 North America Metastatic Prostate Cancer Treatment Market Size (2018-2034)
1.6.2 Europe Metastatic Prostate Cancer Treatment Market Size (2018-2034)
1.6.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2018-2034)
1.6.4 Latin America Metastatic Prostate Cancer Treatment Market Size (2018-2034)
1.6.5 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2018-2034)
2 Metastatic Prostate Cancer Treatment Market by Type
2.1 Introduction
2.1.1 Mono
2.1.2 Combination
2.1.3 Mono/Combination
2.2 Global Metastatic Prostate Cancer Treatment Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Metastatic Prostate Cancer Treatment Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Metastatic Prostate Cancer Treatment Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Metastatic Prostate Cancer Treatment Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Metastatic Prostate Cancer Treatment Revenue Breakdown by Type (2018-2034)
3 Metastatic Prostate Cancer Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Drug Store
3.1.3 Online Pharmacy
3.2 Global Metastatic Prostate Cancer Treatment Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Metastatic Prostate Cancer Treatment Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Metastatic Prostate Cancer Treatment Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Metastatic Prostate Cancer Treatment Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Metastatic Prostate Cancer Treatment Revenue Breakdown by Application (2018-2034)
4 Metastatic Prostate Cancer Treatment Competition Analysis by Players
4.1 Global Metastatic Prostate Cancer Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2022)
4.3 Date of Key Players Enter into Metastatic Prostate Cancer Treatment Market
4.4 Global Top Players Metastatic Prostate Cancer Treatment Headquarters and Area Served
4.5 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Metastatic Prostate Cancer Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AB Science
5.1.1 AB Science Profile
5.1.2 AB Science Main Business
5.1.3 AB Science Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.1.4 AB Science Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 AB Science Recent Developments
5.2 BeiGene
5.2.1 BeiGene Profile
5.2.2 BeiGene Main Business
5.2.3 BeiGene Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.2.4 BeiGene Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 BeiGene Recent Developments
5.3 eFFECTOR Therapeutics
5.3.1 eFFECTOR Therapeutics Profile
5.3.2 eFFECTOR Therapeutics Main Business
5.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.3.4 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.3.5 Immunomedics(Gilead Sciences, Inc.) Recent Developments
5.4 Immunomedics(Gilead Sciences, Inc.)
5.4.1 Immunomedics(Gilead Sciences, Inc.) Profile
5.4.2 Immunomedics(Gilead Sciences, Inc.) Main Business
5.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.4.4 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Developments
5.5 Myovant Biosciences
5.5.1 Myovant Biosciences Profile
5.5.2 Myovant Biosciences Main Business
5.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.5.4 Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.5.5 Myovant Biosciences Recent Developments
5.6 SeleXel
5.6.1 SeleXel Profile
5.6.2 SeleXel Main Business
5.6.3 SeleXel Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.6.4 SeleXel Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.6.5 SeleXel Recent Developments
5.7 Zenith Epigenetics Ltd.
5.7.1 Zenith Epigenetics Ltd. Profile
5.7.2 Zenith Epigenetics Ltd. Main Business
5.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.7.4 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.7.5 Zenith Epigenetics Ltd. Recent Developments
5.8 VasGene Therapeutics, Inc.
5.8.1 VasGene Therapeutics, Inc. Profile
5.8.2 VasGene Therapeutics, Inc. Main Business
5.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.8.4 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.8.5 VasGene Therapeutics, Inc. Recent Developments
5.9 Telix Pharmaceuticals
5.9.1 Telix Pharmaceuticals Profile
5.9.2 Telix Pharmaceuticals Main Business
5.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.9.4 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.9.5 Telix Pharmaceuticals Recent Developments
5.10 Arvinas Inc.
5.10.1 Arvinas Inc. Profile
5.10.2 Arvinas Inc. Main Business
5.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.10.4 Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.10.5 Arvinas Inc. Recent Developments
5.11 Amgen
5.11.1 Amgen Profile
5.11.2 Amgen Main Business
5.11.3 Amgen Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.11.4 Amgen Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.11.5 Amgen Recent Developments
5.12 Genentech
5.12.1 Genentech Profile
5.12.2 Genentech Main Business
5.12.3 Genentech Metastatic Prostate Cancer Treatment Products, Services and Solutions
5.12.4 Genentech Metastatic Prostate Cancer Treatment Revenue (US$ Million) & (2018-2024)
5.12.5 Genentech Recent Developments
6 North America
6.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2018-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metastatic Prostate Cancer Treatment Market Dynamics
11.1 Metastatic Prostate Cancer Treatment Industry Trends
11.2 Metastatic Prostate Cancer Treatment Market Drivers
11.3 Metastatic Prostate Cancer Treatment Market Challenges
11.4 Metastatic Prostate Cancer Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Metastatic Prostate Cancer Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Metastatic Prostate Cancer Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Metastatic Prostate Cancer Treatment Market Size Share by Region (2018-2024)
Table 4. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Metastatic Prostate Cancer Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America Metastatic Prostate Cancer Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Metastatic Prostate Cancer Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Metastatic Prostate Cancer Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Metastatic Prostate Cancer Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Metastatic Prostate Cancer Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Metastatic Prostate Cancer Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Metastatic Prostate Cancer Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America Metastatic Prostate Cancer Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Metastatic Prostate Cancer Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Metastatic Prostate Cancer Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Metastatic Prostate Cancer Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Metastatic Prostate Cancer Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Metastatic Prostate Cancer Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Metastatic Prostate Cancer Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2022)
Table 39. Date of Key Players Enter into Metastatic Prostate Cancer Treatment Market
Table 40. Global Metastatic Prostate Cancer Treatment Key Players Headquarters and Area Served
Table 41. Metastatic Prostate Cancer Treatment Product Solution and Service
Table 42. Global Metastatic Prostate Cancer Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AB Science Basic Information List
Table 45. AB Science Description and Business Overview
Table 46. AB Science Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of AB Science (2018-2024)
Table 48. AB Science Recent Developments
Table 49. BeiGene Basic Information List
Table 50. BeiGene Description and Business Overview
Table 51. BeiGene Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of BeiGene (2018-2024)
Table 53. BeiGene Recent Developments
Table 54. eFFECTOR Therapeutics Basic Information List
Table 55. eFFECTOR Therapeutics Description and Business Overview
Table 56. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of eFFECTOR Therapeutics (2018-2024)
Table 58. eFFECTOR Therapeutics Recent Developments
Table 59. Immunomedics(Gilead Sciences, Inc.) Basic Information List
Table 60. Immunomedics(Gilead Sciences, Inc.) Description and Business Overview
Table 61. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Immunomedics(Gilead Sciences, Inc.) (2018-2024)
Table 63. Immunomedics(Gilead Sciences, Inc.) Recent Developments
Table 64. Myovant Biosciences Basic Information List
Table 65. Myovant Biosciences Description and Business Overview
Table 66. Myovant Biosciences Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Myovant Biosciences (2018-2024)
Table 68. Myovant Biosciences Recent Developments
Table 69. SeleXel Basic Information List
Table 70. SeleXel Description and Business Overview
Table 71. SeleXel Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of SeleXel (2018-2024)
Table 73. SeleXel Recent Developments
Table 74. Zenith Epigenetics Ltd. Basic Information List
Table 75. Zenith Epigenetics Ltd. Description and Business Overview
Table 76. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Zenith Epigenetics Ltd. (2018-2024)
Table 78. Zenith Epigenetics Ltd. Recent Developments
Table 79. VasGene Therapeutics, Inc. Basic Information List
Table 80. VasGene Therapeutics, Inc. Description and Business Overview
Table 81. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of VasGene Therapeutics, Inc. (2018-2024)
Table 83. VasGene Therapeutics, Inc. Recent Developments
Table 84. Telix Pharmaceuticals Basic Information List
Table 85. Telix Pharmaceuticals Description and Business Overview
Table 86. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Telix Pharmaceuticals (2018-2024)
Table 88. Telix Pharmaceuticals Recent Developments
Table 89. Arvinas Inc. Basic Information List
Table 90. Arvinas Inc. Description and Business Overview
Table 91. Arvinas Inc. Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Arvinas Inc. (2018-2024)
Table 93. Arvinas Inc. Recent Developments
Table 94. Amgen Basic Information List
Table 95. Amgen Description and Business Overview
Table 96. Amgen Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Amgen (2018-2024)
Table 98. Amgen Recent Developments
Table 99. Genentech Basic Information List
Table 100. Genentech Description and Business Overview
Table 101. Genentech Metastatic Prostate Cancer Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Metastatic Prostate Cancer Treatment Business of Genentech (2018-2024)
Table 103. Genentech Recent Developments
Table 104. North America Metastatic Prostate Cancer Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 105. North America Metastatic Prostate Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 106. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 107. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 108. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 109. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 110. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 111. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2018-2024)
Table 112. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2024-2034)
Table 113. Latin America Metastatic Prostate Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 114. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 115. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 116. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 117. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 118. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 119. Metastatic Prostate Cancer Treatment Market Trends
Table 120. Metastatic Prostate Cancer Treatment Market Drivers
Table 121. Metastatic Prostate Cancer Treatment Market Challenges
Table 122. Metastatic Prostate Cancer Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Prostate Cancer Treatment Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Metastatic Prostate Cancer Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global Metastatic Prostate Cancer Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Metastatic Prostate Cancer Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Metastatic Prostate Cancer Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Metastatic Prostate Cancer Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Mono
Figure 11. Global Mono Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Combination
Figure 13. Global Combination Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Mono/Combination
Figure 15. Global Mono/Combination Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Global Metastatic Prostate Cancer Treatment Market Size Share by Type: 2022 & 2034
Figure 17. North America Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2034)
Figure 18. Europe Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2034)
Figure 19. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2034)
Figure 20. Latin America Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2034)
Figure 21. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2018-2034)
Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Drug Store Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Online Pharmacy Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Global Metastatic Prostate Cancer Treatment Market Size Share by Application: 2022 & 2034
Figure 26. North America Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2034)
Figure 27. Europe Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2034)
Figure 28. Asia-Pacific Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2034)
Figure 29. Latin America Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2034)
Figure 30. Middle East and Africa Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2018-2034)
Figure 31. Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Metastatic Prostate Cancer Treatment Market Share in 2022
Figure 33. North America Metastatic Prostate Cancer Treatment Market Share by Country (2018-2034)
Figure 34. United States Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 35. Canada Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 36. Germany Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 37. France Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 38. U.K. Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 39. Italy Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 40. Russia Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 41. Nordic Countries Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 42. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2018-2034)
Figure 43. China Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 44. Japan Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 45. South Korea Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 46. Southeast Asia Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 47. India Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 48. Australia Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 49. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2018-2034)
Figure 50. Mexico Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 51. Brazil Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2018-2034)
Figure 53. Turkey Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 55. UAE Metastatic Prostate Cancer Treatment Market Size (2018-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries